Bayer Shares Outstanding 2006-2019 | BAYRY

Bayer shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Bayer shares outstanding for the quarter ending September 30, 2019 were 3.930B, a 0.23% increase year-over-year.
  • Bayer 2018 shares outstanding were 3.763B, a 7.87% increase from 2017.
  • Bayer 2017 shares outstanding were 3.488B, a 4.76% increase from 2016.
  • Bayer 2016 shares outstanding were 3.33B, a 0.67% increase from 2015.
Bayer Annual Shares Outstanding
(Millions of Shares)
2018 3,763
2017 3,488
2016 3,330
2015 3,308
2014 3,308
2013 3,308
2012 3,308
2011 3,304
2010 3,315
2009 3,198
2008 3,106
2007 3,230
2006 3,032
2005 2,913
Bayer Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 3,930
Q2 2019 3,927
Q1 2019 3,921
Q4 2018 3,763
Q3 2018 3,921
Q2 2018 3,663
Q1 2018 3,490
Q4 2017 3,488
Q3 2017 3,490
Q2 2017 3,488
Q1 2017 3,308
Q4 2016 3,330
Q3 2016 3,320
Q2 2016 3,305
Q1 2016 3,302
Q4 2015 3,308
Q3 2015 3,302
Q2 2015 3,314
Q1 2015 3,299
Q4 2014 3,308
Q3 2014 3,304
Q2 2014 3,315
Q1 2014 3,309
Q4 2013 3,308
Q3 2013 3,294
Q2 2013 3,298
Q1 2013 3,314
Q4 2012 3,308
Q3 2012 3,300
Q2 2012 3,293
Q1 2012 3,307
Q4 2011 3,308
Q3 2011 3,308
Q2 2011 3,308
Q1 2011 3,296
Q4 2010 2,417
Q3 2010 3,308
Q2 2010 3,308
Q1 2010 3,308
Q4 2009 3,400
Q3 2009 3,308
Q2 2009 3,140
Q1 2009 3,091
Q4 2008 3,298
Q3 2008 2,995
Q2 2008 3,184
Q1 2008 3,175
Q4 2007
Q3 2007 3,219
Q2 2007 3,181
Q1 2007 3,266
Q4 2006
Q3 2006 3,048
Q2 2006 3,013
Q1 2006 2,912
Q4 2005
Q3 2005 2,918
Q2 2005 2,943
Q1 2005 2,927
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $77.588B $46.752B
Bayer AG, best known for its flagship product, Bayer Aspirin, produces a broad range of health care, crop protection, polymer, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.359B 17.09
Roche Holding AG (RHHBY) Switzerland $282.158B 0.00
Pfizer (PFE) United States $220.369B 13.10
Merck (MRK) United States $218.904B 16.96
Novartis AG (NVS) Switzerland $215.131B 18.16
Novo Nordisk (NVO) Denmark $144.638B 24.93
Eli Lilly (LLY) United States $133.525B 24.66
AstraZeneca (AZN) United Kingdom $129.299B 23.35
AbbVie (ABBV) United States $123.541B 9.68
Sanofi (SNY) France $122.027B 14.99
GlaxoSmithKline (GSK) United Kingdom $117.802B 14.27
Bristol-Myers Squibb (BMY) United States $104.535B 14.61
H Lundbeck (HLUYY) Denmark $8.147B 14.16